Association between TERT hypermethylation and immunotherapy responses. A, Significant immune-related pathways that were derived from GSEA of TERT methylation-related genes when comparing PMME and NEMM. B, Significant immune-related pathways derived from GSEA of TERT methylation-related genes when comparing PMME and normal controls. The infiltration level differences of CD8⁺ T cells (C) and activated CD4⁺ memory T cells (D) in patients with TERThi and TERTlow PMME (*, P < 0.05). E, PFS differences between patients with TERThi and TERTlow NEMM receiving immunotherapy. F, Case demonstrations of 3 patients with PMME (P1, P7, and P13) who received anti-PD-1 immunotherapy during their treatment course. DDP, cisplatin.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: